Stockscreener 앱 받기
34.05
1.33%
-0.46
시장 영업 전:
33.70
-0.35
-1.03%
Roivant Sciences Ltd 주식(ROIV)의 최신 뉴스
Why is Billionaire Joe Edelman Bullish on Roivant Sciences (ROIV) - Kavout | AI
Pfizer, BioNTech face global patent suits from Arbutus, Roivant over COVID vaccine tech - Seeking Alpha
Roivant unit Genevant, Arbutus file patent infringement suits against Pfizer, BioNTech over LNP technology - Bitget
ROIV Stock Nears Record High –Retail Traders See Breakout After Surprise Earnings Beat - Stocktwits
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 9.47% Upside Potential in Biotech Innovation - DirectorsTalk Interviews
Roivant Sciences (ROIV) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Roivant’s Gline: From spin-cos to commercial conviction - biocentury.com
Roivant Sciences (ROIV) Climbs 2%: Biotech Stock Tests Key Resistance Near $38.65Moving Average Ribbon - dars.gov.et
Responsive Playbooks and the ROIV Inflection - Stock Traders Daily
Roivant Sciences (ROIV) TD Cowen 45th Annual Healthcare Conference Summary - Quartr
Roivant Sciences stock hits all-time high at 35.92 USD By Investing.com - Investing.com Nigeria
Roivant Sciences stock hits all-time high at 35.92 USD - Investing.com
Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years? - Yahoo Finance
Roivant Sciences Ltd. (ROIV) Stock Analysis: Potential Upside Amidst Biotech Innovations - DirectorsTalk Interviews
If You Invested $1,000 in Roivant Sciences (ROIV) - Stock Titan
ROIVRoivant Sciences Ltd Dividends - Finviz
Roivant Sciences Insider Sold Shares Worth $610,252, According to a Recent SEC Filing - Moomoo
Roivant Sciences (ROIV) director exercises options, sells 10,000 common shares - Stock Titan
Roivant Sciences (ROIV) Left Key Russell Indexes, Is It Still 10% Below Fair Value? - simplywall.st
76K Roivant (ROIV) shares withheld for CEO Matthew Gline RSU tax payment - Stock Titan
Roivant Sciences (ROIV) director sells 17,750 shares after exercising options - Stock Titan
Roivant Sciences Insider Sold Shares Worth $56,444,076, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences Insider Sold Shares Worth $49,354,076, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences (ROIV) director-linked entity reports 1.44M-share open-market sale - Stock Titan
Form 144 ROIVANT SCIENCES LTD. For: 30 June - Investing.com UK
Roivant Sciences(ROIV.US) Director Sells US$56.44 Million in Common Stock - Moomoo
Roivant Sciences Director Sold Shares Worth Over $56M - TradingView
Form 144 ROIVANT SCIENCES LTD. For: 30 June By Investing.com - Investing.com Nigeria
Is Roivant Sciences (ROIV) Losing Its Defensive Status or Reframing Its Risk Narrative? - simplywall.st
Roivant Sciences Insider Sold Shares Worth $34,105,000, According to a Recent SEC Filing - Moomoo
Roivant Sciences Ltd.(NasdaqGS: ROIV) dropped from Russell 1000 Value-Defensive Index - marketscreener.com
Roivant Sciences Ltd.(NasdaqGS: ROIV) dropped from Russell 1000 Defensive Index - marketscreener.com
Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with 14.59% Potential Upside - DirectorsTalk Interviews
Roivant Sciences Insider Sold Shares Worth $6,631,268, According to a Recent SEC Filing - Moomoo
Understanding the Setup: (ROIV) and Scalable Risk - Stock Traders Daily
Price to sales forward of Roivant Sciences Ltd. – NASDAQ:ROIV - TradingView
Enterprise value to revenue forward of Roivant Sciences Ltd. – NASDAQ:ROIV - TradingView
Enterprise value to revenue forward of Roivant Sciences Ltd. – DUS:87S - TradingView
Enterprise value to EBITDA forward of Roivant Sciences Ltd. – DUS:87S - TradingView
Enterprise value to EBIT forward of Roivant Sciences Ltd. – NASDAQ:ROIV - TradingView
Form 144 ROIVANT SCIENCES LTD. For: 26 June - Investing.com UK
Form 144 ROIVANT SCIENCES LTD. For: 26 June By Investing.com - Investing.com Nigeria
Price to earnings forward of Roivant Sciences Ltd. – NASDAQ:ROIV - TradingView
Roivant Sciences(ROIV.US) Officer Sells US$6.63 Million in Common Stock - Moomoo
Roivant (NASDAQ: ROIV) president sells 200K shares, exercises 200K stock options - Stock Titan
Form 144 ROIVANT SCIENCES LTD. For: 25 June - Investing.com UK
Form 144 ROIVANT SCIENCES LTD. For: 25 June By Investing.com - Investing.com South Africa
Roivant Sciences Ltd (ROIV) Institutional Confidence - TradingKey
JNJ Stock Price and Chart — NYSE:JNJ - TradingView
Price to book forward of Roivant Sciences Ltd. – NASDAQ:ROIV - TradingView
3.77%
0.74%
자본화:
|
볼륨(24시간):